Riskpilot← Back to searchSign inGet full accessNovo Nordisk Pharmatech A/S
A/SActiveCVR 13246149Københavnsvej 216Manufacture of pharmaceutical preparations · NACE 2120Est. 1989532 employees
Revenue 2025
DKK 1B
+9% vs 2024
EBITDA margin
10.6%
+50% vs 2024
Equity ratio
79.6%
Financial strength
Net profit 2025
DKK 113,9M
+88% vs 2024
| Revenue | DKK 1B | +9% |
| EBITDA | DKK 110M | +50% |
| Net profit | DKK 113,9M | +88% |
| Total assets | DKK 3,1B | +56% |
| Equity | DKK 2,4B | +84% |
| Employees | 532 | — |
Legal name
Novo Nordisk Pharmatech A/S
CVR number
13246149
Legal form
Aktieselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
1. juli 1989
Share capital
DKK 10.003.000
Employees
532 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsesformanden og direktøren i forening eller af bestyrelsesformanden og 1 medlem af bestyrelsen i forening eller af 3 bestyrelsesmedlemmer i forening eller af den samlede bestyrelse
Company purpose
Selskabets formål er at drive handel og industri
Address
Københavnsvej 216
Phone
+4556671000
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 619.083 | 598.265 | 880.400 | 956.033 | 1.041.584 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 147.120 | 41.876 | 90.301 | 73.479 | 110.044 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 147.120 | 41.876 | 90.301 | 73.479 | 110.044 |
| Net financials | -412 | 7.379 | 8.390 | 3.817 | 35.278 |
| Profit before tax | 146.708 | 49.255 | 98.691 | 77.296 | 145.322 |
| Tax | 32.960 | 9.948 | 21.444 | 16.677 | 31.431 |
| Net profit | 113.748 | 39.307 | 77.247 | 60.619 | 113.891 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 639.924 | 966.914 | 1.266.562 | 1.962.701 | 3.066.139 |
| Equity | 520.247 | 689.619 | 766.912 | 1.327.620 | 2.441.318 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 90.539 | 234.231 | 458.447 | 593.552 | 579.402 |
| Total debt | 90.539 | 234.231 | 458.447 | 635.082 | 624.821 |
EBITDA margin
10.6%
This company
15.8%
Market median
-33% vs market
20212025
Equity ratio
79.6%
This company
38.2%
Market median
+108% vs market
20212025
Return on equity
4.7%
This company
18.4%
Market median
-74% vs market
20212025
Net profit margin
10.9%
This company
8.1%
Market median
+35% vs market
20212025
Asset turnover
0.34×
This company
1.12×
Market median
-70% vs market
20212025
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
UG Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (16) | ||
SD Management | Management | 2003 – 2012 |
BH Chief Executive Officer | Chief Executive Officer | 2021 – 2021 |
ET | Audit | 1989 – 1990 |
KE | Deputy | 2020 – 2024 |
JF Deputy | Deputy | 2004 – 2008 |
HP Deputy | Deputy | 2024 – 2025 |
VM Deputy | Deputy | 2016 – 2020 |
LS Deputy | Deputy | 2016 – 2018 |
LD Deputy | Deputy | 2012 – 2015 |
LB Deputy | Deputy | 2008 – 2012 |
BM | Deputy | 2000 – 2004 |
PE Deputy | Deputy | 2008 – 2012 |
LT Deputy | Deputy | 2004 – 2008 |
PE Management | Management | 1989 – 2003 |
PE Management | Management | 1989 – 1990 |
RH Chief Executive Officer | Chief Executive Officer | 2012 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Board of Directors | 2020 | |
| Board of Directors | 2016 | |
| Board of Directors | 2025 | |
| Board of Directors | 2021 | |
| Board of Directors | 2024 | |
| Chairman | 2026 | |
| Former (40) | ||
| Board of Directors | 2017 – 2020 | |
| Board of Directors | 1989 – 1995 | |
| Board of Directors | 1989 – 1995 | |
| Board of Directors | 1989 – 1990 | |
| Board of Directors | 2004 – 2007 | |
| Board of Directors | 1989 – 1994 | |
| Board of Directors | 2012 – 2016 | |
| Board of Directors | 1989 – 1995 | |
| Board of Directors | 1989 – 2001 | |
| Board of Directors | 2023 – 2025 | |
| Board of Directors | 2020 – 2024 | |
| Board of Directors | 2000 – 2018 | |
| Board of Directors | 2000 – 2016 | |
| Chairman | 2000 – 2015 | |
| Board of Directors | 1989 – 2000 | |
| Board of Directors | 1997 – 1999 | |
| Board of Directors | 1989 – 2000 | |
| Board of Directors | 1989 – 1993 | |
| Board of Directors | 1989 – 1995 | |
| Board of Directors | 1989 – 1994 | |
| Board of Directors | 1996 – 2000 | |
| Board of Directors | 1989 – 1997 | |
| Board of Directors | 1989 – 1997 | |
| Board of Directors | 1989 – 2000 | |
| Board of Directors | 2008 – 2012 | |
| Chairman | 2015 – 2020 | |
| Board of Directors | 2015 – 2019 | |
| Board of Directors | 2012 – 2020 | |
JH | Board of Directors | 2012 – 2015 |
| Board of Directors | 2018 – 2023 | |
| Board of Directors | 2000 – 2009 | |
| Chairman | 2020 – 2026 | |
| Board of Directors | 1989 – 1996 | |
| Board of Directors | 2007 – 2009 | |
| Board of Directors | 2009 – 2011 | |
| Chairman | 1989 – 1990 | |
| Board of Directors | 2000 – 2008 | |
| Board of Directors | 1989 – 1995 | |
| Board of Directors | 1989 – 1994 | |
| Board of Directors | 1989 – 1994 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 1989 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NOVO NORDISK FONDEN
Novo Nordisk Pharmatech A/S Board members of Novo Nordisk Pharmatech A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Søren Damtoft | Management | 0 companies |
| Bo Højriis Frandsen | Chief Executive Officer | 0 companies |
| Erik Tronborg Andersen | Audit | 0 companies |
| Knud Edgar Striib Nielsen | Deputy | 0 companies |
| Jesper Frank Morthensen | Deputy | 0 companies |
| Hazal Polat | Deputy | 0 companies |
| Vesna Maria Schneider | Deputy | 0 companies |
| Lars Sørensen | Deputy | 0 companies |
| Lene Due Svensson | Deputy | 0 companies |
| Lars Bjørk | Deputy | 0 companies |
| Bente Margrethe Skov Schultz | Deputy | 0 companies |
| Poul Erik Noer Søderdahl | Deputy | 0 companies |
| Louise Thiel | Deputy | 0 companies |
| Preben Engelund Poulsen | Management | 0 companies |
| Per Emil Hasselbalch Stakemann | Management | 0 companies |
| Ulla Grove Krogsgaard Thomsen | Chief Executive Officer | 0 companies |
| Rasmus Hother le Fevre | Chief Executive Officer | 0 companies |
| Claus Steensen Sølje | Board of Directors | 0 companies |
| Keld Pedersen | Board of Directors | 0 companies |
| Richardt Sonnichsen | Board of Directors | 0 companies |
| Tue Micheelsen | Board of Directors | 0 companies |
| Ulf Svejgaard Poulsen | Board of Directors | 0 companies |
| Joachim Juel Hagemeister | Board of Directors | 0 companies |
| Kim Tosti Nielsen | Board of Directors | 0 companies |
| Kjell Hans Bakke | Board of Directors | 0 companies |
| Peter Helt Jacobsen Haahr | Board of Directors | 0 companies |
| Sonnich Jacob Fryland | Board of Directors | 0 companies |
| Karina Sinding | Board of Directors | 0 companies |
| Per Andersen | Board of Directors | 0 companies |
| Julie Aunbirk | Board of Directors | 0 companies |
| Zohra Mansour | Board of Directors | 0 companies |
| Ole Falvig Ramsby | Board of Directors | 0 companies |
| Erik Frederik Johannes Mortensen | Board of Directors | 0 companies |
| Jacob Sten Petersen | Board of Directors | 0 companies |
| Per Toft Valstorp | Chairman | 0 companies |
| Kim Antero Bjørnholt | Board of Directors | 0 companies |
| Steen Skjold-Jørgensen | Board of Directors | 0 companies |
| Jens Hartvig Jørgensen | Board of Directors | 0 companies |
| Jonna Annelise Skovager | Board of Directors | 0 companies |
| Bente Hornbech Grubbe | Board of Directors | 0 companies |
| Jørgen Grønlund Nielsen | Board of Directors | 0 companies |
| Poul Lasse Jespersen | Board of Directors | 0 companies |
| Bjarne Mølgaard Knudsen | Board of Directors | 0 companies |
| Ole Regnar Hansen | Board of Directors | 0 companies |
| Hans Georg Boye Nielsen | Board of Directors | 0 companies |
| Camilla Mølbak Sønderris | Board of Directors | 0 companies |
| Henrik Ehlers Wulff | Chairman | 0 companies |
| Michael Fugl Hallgren | Board of Directors | 0 companies |
| Christian Brøgger Stolberg | Board of Directors | 0 companies |
| Henrik Kaj Dvinge | Board of Directors | 0 companies |
| Jan Hoff | Board of Directors | 0 companies |
| Søren Thor Jensen | Board of Directors | 0 companies |
| Mette Sofie Mørck Jarl | Chairman | 0 companies |
| Jesper Giede Bøving | Board of Directors | 0 companies |
| Jean Fabian Jeldorf | Chairman | 0 companies |
| Birgit Mindegaard | Board of Directors | 0 companies |
| Jesper Kløve | Board of Directors | 0 companies |
| Susanne Møberg Hundsbæk-Pedersen | Board of Directors | 0 companies |
| Susanne Saul Stakemann | Chairman | 0 companies |
| Eva Kjer Hansen | Board of Directors | 0 companies |
| Bjarne Tommy Pedersen | Board of Directors | 0 companies |
| Kurt Anker Nielsen | Board of Directors | 0 companies |
| Bent Stig Vase | Board of Directors | 0 companies |